Tethis, MACS and Everex announce transfer of See.d® business unit and long-term manufacturing partnership

PartnershipSee.d®Positive

AI Analysis

Summary

Tethis, MACS, and Everex announced the completion of a transfer of the See.d® business unit and established a long-term manufacturing partnership for standardized blood-derived cellular sample preparation used in liquid biopsy and AI-assisted cell analysis.

Outcome Details

Transfer of See.d® business unit and long-term manufacturing partnership completed

Importance:4/10

Sentiment:

0.30

business transfermanufacturing partnershipliquid biopsydigital cytologycell analysis

Read the original article

Published by PR Newswire Biotech on September 21, 2026 4:00 PM

Read Original